Granules India has informed that it enclosed the press release given by the Company titled ‘Granules Pharmaceuticals Inc. Receives FDA Tentative Approval for Generic Amphetamine Extended-Release Orally Disintegrating Tablets (ADZENYS XR-ODT®)’.
The above information is a part of company’s filings submitted to BSE.